{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:53:04Z","timestamp":1776203584522,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010132","name":"\u00d6sterreichische Nationalstiftung f\u00fcr Forschung, Technologie und Entwicklung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101148","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T23:41:36Z","timestamp":1773531696000},"page":"101148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospective monitoring of the clinical implementation of ultrahypofractionated whole-breast radiotherapy using electronic patient-reported outcome measures"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-1711","authenticated-orcid":false,"given":"Barbara","family":"Kn\u00e4usl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Heilemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4089-5144","authenticated-orcid":false,"given":"Leo","family":"Andexlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-2276","authenticated-orcid":false,"given":"Lukas","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-0919","authenticated-orcid":false,"given":"Andreas","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Georg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9972-6690","authenticated-orcid":false,"given":"Joachim","family":"Widder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-3741","authenticated-orcid":false,"given":"Stefan","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Kauer-Dorner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101148_b0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13014-019-1430-x","article-title":"Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study","volume":"14","author":"Pandeli","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-020-01501-x","article-title":"Recent advances in radiotherapy of breast cancer","volume":"15","author":"Haussmann","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0020","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101148_b0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-025-02481-1","article-title":"DEGRO statement on the FAST-Forward trial: 10-year data of ultrahypofractionated radiation therapy for breast cancer","volume":"202","author":"Matuschek","year":"2026","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2026.101148_b0035","doi-asserted-by":"crossref","first-page":"S4429","DOI":"10.1016\/S0167-8140(25)04201-X","article-title":"Hypofractionated breast radiotherapy for 1 week vs 3 weeks: 10-year efficacy and late normal tissue effects in the FAST-Forward randomised trial","volume":"206","author":"Brunt","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110915","article-title":"Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: results from the phase III FAST-Forward trial randomised nodal sub-study","volume":"207","author":"Brunt","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0045","doi-asserted-by":"crossref","first-page":"111310","DOI":"10.1016\/j.radonc.2025.111310","article-title":"Acute toxicity and quality of life after 5-fraction versus 15-fraction adjuvant radiotherapy following conventional or oncoplastic breast-conserving surgery \u2212 a real-world prospective cohort study","volume":"214","author":"Mink van der Molen","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0050","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac9109","article-title":"Accuracy and potential improvements of surface-guided breast cancer radiotherapy in deep inspiration breath-hold with daily image-guidance","volume":"67","author":"Nankali","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2026.101148_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tipsro.2022.03.003","article-title":"Surface guided radiation therapy: an international survey on current clinical practice","volume":"22","author":"Batista","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13014-020-01629-w","article-title":"Recent advanced in Surface Guided Radiation Therapy","volume":"15","author":"Freislederer","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0065","article-title":"ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation","volume":"28","author":"Mast","year":"2023","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110183","article-title":"Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy","volume":"194","author":"Cicchetti","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13014-016-0701-z","article-title":"Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results","volume":"11","author":"De Rose","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0080","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110427","article-title":"Automation of ePROMs in radiation oncology and its impact on patient response and bias","volume":"199","author":"Heilemann","year":"2024","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.ctro.2026.101148_b0090","article-title":"On the sensitivity of PROMs during breast radiotherapy","volume":"39","author":"Heilemann","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijrobp.2022.05.041","article-title":"A Comparison of Patient- and Clinician-Reported Acute toxic Effects during Radiation Therapy for Primary Breast Cancer","volume":"114","author":"Lapen","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101148_b0100","unstructured":"ClinicalTrials.gov. Patient Experience Data in Radiation Oncology (PEDRO) 2020. https:\/\/clinicaltrials.gov\/study\/NCT05224297 (accessed December 5, 2025)."},{"key":"10.1016\/j.ctro.2026.101148_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctro.2026.101148_b0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.ctro.2026.101148_b0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00432-021-03907-w","article-title":"Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly\/frail patients treated with 3D and IMRT technique","volume":"148","author":"Zerella","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11136-008-9430-6","article-title":"The applications of PROs in clinical practice: what are they, do they work, and why?","volume":"18","author":"Greenhalgh","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ctro.2026.101148_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"Guidance for industry","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctro.2026.101148_b0135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1524-4733.2007.00231.x","article-title":"Equivalence of Electronic and Paper-and-Pencil Administration of Patient-Reported Outcome Measures: a Meta-Analytic Review","volume":"11","author":"Gwaltney","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.ctro.2026.101148_b0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmrs.711","article-title":"Patients\u2019 experiences of engaging with electronic Patient Reported Outcome measures (PROMs) after the completion of radiation therapy for breast cancer: a pilot service evaluation","volume":"70","author":"Hughes","year":"2023","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.ctro.2026.101148_b0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12955-023-02087-0","article-title":"Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity","volume":"21","author":"Deutscher","year":"2023","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctro.2026.101148_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111301","article-title":"Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials","volume":"214","author":"Ng","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011975","article-title":"Electronic capture of patient-reported and clinician-reported outcome measures in an elective orthopaedic setting: a retrospective cohort analysis","volume":"6","author":"Malhotra","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctro.2026.101148_b0160","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1200\/JCO.23.02150","article-title":"FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in older patients with Cancer-a Multicenter prospective Study","volume":"42","author":"Cancel","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0165","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ijrobp.2023.06.213","article-title":"Physician and Patient-Reported Outcomes of a phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the whole Breast after Breast-Conserving Surgery","volume":"117","author":"Laughlin","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101148_b0170","article-title":"Volumetric Modulated Arc Therapy for 26 Gy in 5 Fractions whole Breast Irradiation for Breast Cancer","volume":"10","author":"Hee Choi","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.coc.0000197661.09628.03","article-title":"Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer","volume":"29","author":"Freedman","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101148_b0180","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.ijrobp.2022.07.717","article-title":"Patient Reported Quality of Life Outcomes and Patient Satisfaction of 1-Week Hypofractionated whole Breast Radiation Therapy using IMRT for Early-Stage Breast Cancer","volume":"114","author":"Naziri","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101148_b0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.meddos.2023.04.003","article-title":"Delivery of a VMAT technique with flattening filter (FF) and flattening filter free (FFF) mode for whole breast irradiation with five fractions (FAST-Forward trial)","volume":"48","author":"Akhtaruzzaman","year":"2023","journal-title":"Med Dosim"},{"key":"10.1016\/j.ctro.2026.101148_b0190","first-page":"611","article-title":"Ultra-Hypofractionated whole Breast Radiotherapy with Automated Hybrid-VMAT Technique: a pilot Study on Safety, Skin Toxicity and Aesthetic Outcomes","volume":"16","author":"Boccardi","year":"2024","journal-title":"Breast Cancer"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:02:57Z","timestamp":1776200577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S2405630826000431"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101148","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective monitoring of the clinical implementation of ultrahypofractionated whole-breast radiotherapy using electronic patient-reported outcome measures","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101148"}}